Oxolin-Darnytsia Ointment 2.5 mg/g – 10 g Antiviral Nasal

Oxolin-Darnytsia Ointment 2.5 mg/g – 10 g Antiviral Nasal

Oxolin-Darnytsia Ointment 2.5 mg/g (10 g tube) is a classic antiviral topical preparation used to support the body’s defense against common viral infections of the upper respiratory tract. Its active ingredient oxolinum is recognised for its ability to block viral attachment to host cells, helping to prevent and alleviate viral rhinitis, influenza and related infections when applied to the nasal mucosa or other mucous membranes.

Originally developed as an external antiviral agent, Oxolin-Darnytsia works by creating a protective surface layer on the skin and mucous membranes that can interfere with early stages of viral colonisation and replication. Because oxolinum does not enter the bloodstream in significant amounts when used topically, the ointment’s action is local rather than systemic, making it suitable for direct application during seasonal respiratory outbreaks or after contact with infected individuals.

The product is supplied in a 10 g tube with a moderate concentration of oxolinum (approximately 2.5 mg per gram of ointment), ensuring consistent application and dosing for everyday supportive use.

How Oxolin-Darnytsia Ointment Works

Oxolinum has virus-inhibiting (virucidal) properties that help prevent certain viruses from binding to cell surfaces. When applied to the nasal mucosa or skin areas prone to viral invasion — such as around the nostrils — oxolinum may help reduce the likelihood that viruses will enter cells and replicate.

Although the exact mechanism is rooted in surface interference with viral penetration, numerous traditional and clinical applications rely on its preventive and supportive effects during seasonal respiratory infection waves.

Indications — When to Use Oxolin-Darnytsia

Oxolin-Darnytsia ointment is primarily indicated for:

• Prevention of influenza and seasonal respiratory viral infections.

• Supportive care in viral rhinitis (inflammation of the nasal mucous membranes caused by viruses).

• Prevention of recurrent cold symptoms during periods of high infection rates or after exposure to sick individuals.

• Traditional use in localised viral skin conditions such as herpes simplex on lips, though this varies by region and formulation.

This ointment does not cure viral infections but can be part of a preventive or early support strategy in combination with lifestyle and hygiene measures during outbreaks.

Directions for Use

Oxolin-Darnytsia ointment is designed for external use only. The most common method of application is:

1. Clean the application area gently before use.

2. Apply a thin layer of ointment to the nasal mucosa or affected skin areas 2–3 times daily.

3. For influenza prevention: continue daily use for approximately 25 days during peak seasonal risk or after close contact with infected individuals.

4. For viral rhinitis treatment: apply 2–3 times daily for 3–4 days until symptoms ease.

Do not rub the ointment into the skin aggressively — a thin, even layer provides the best protective effect.

Safety and Precautions

Although Oxolin-Darnytsia is generally well tolerated when used as directed, certain precautions should be observed:

• Not for internal use. Do not ingest the ointment.

• Allergy and sensitivity: avoid use if you have known hypersensitivity to oxolinum or any excipients.

• Sensitive mucosa: in rare cases, application to mucous membranes may cause short-lived burning, irritation or rhinorrhea (runny nose).

• Not recommended for use in pregnancy or breastfeeding without professional guidance due to insufficient safety data.

• Children: clinical studies in children are limited, so use in young children should be conservative and under medical supervision.

If irritation persists or worsens, discontinue use and consult a healthcare provider.

Possible Side Effects

Possible reactions are typically mild and localized:

• Temporary burning sensations at the application site.

• Occasional runny nose (rhinorrhea) following nasal application.

• Rare reports of skin discoloration where the ointment was applied — this usually resolves with discontinuation.

If significant irritation or allergic symptoms such as rash or swelling occur, stop use and seek medical advice.

Storage and Shelf Life

Store Oxolin-Darnytsia ointment in the original packaging at temperatures below 8–15 °C (depending on instructions) and keep it out of direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiration date printed on the tube.

Why Choose Oxolin-Darnytsia Ointment

Oxolin-Darnytsia is a time-tested topical antiviral agent trusted in many regions as part of seasonal prophylactic care for respiratory infections. Its ease of application, local action and established traditional use make it a common choice for people seeking supportive protection during cold and flu seasons, especially in combination with good hygiene and preventive health routines.